CompletedNot Applicable

The Role of Ovarian PRP Therapy in Poseidon Poor Responders Women Undergoing ICSI Cycle

Iraq102 participantsStarted 2024-01-01

Plain-language summary

Objective : This study aims to evaluate the impact of ovarian PRP therapy compared to control in Poseidon females undergoing ICSI cycles. Material and Methods: A randomized controlled trial was conducted from Jan 2024 to Feb 2025, involving 102 Poseidon women, Participants were divided into a PRP group (n=50), who received ovarian PRP injections and a control group (n=52), who received no PRP. All participants underwent ICSI cycles, embryological and pregnancy outcomes were compared between both groups within each Poseidon group.

Who can participate

Age range21 Years – 49 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: 1 - infertile Poseidon groups 2, 3, 4 women 2- no history of chronic illness or pelvic pathology. 3- All male partners were either normozoospermic or had mild OAT delivered fresh ejaculated samples for ICSI. Exclusion Criteria: 1 - ovarian failure due to sex chromosome abnormalities, 2- current use of anticoagulants 3- history of bleeding disorders.

What they're measuring

numbers of Meta phase II oocytes and embryos post ovarian PRP

Timeframe: one year

Trial details

NCT IDNCT07199868

SponsorKarbala University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-02-28

View on ClinicalTrials.gov More Poor Ovarian Reserve trials